First reported cases of intravascular large cell lymphoma of the NK cell type: Clinical, histologic, immunophenotypic, and molecular features

American Journal of Clinical Pathology

Volumn 123, Issue 4, 2005, Pages 603-611

  Wu, Huiqing ^a   Said, Jonathan W ^b   Ames, Elizabeth D ^e   Chen, Chen ^b   McWhorter, Valerie ^b   Chen, Peter ^c   Ghali, Violette ^d   Pinkus, Geraldine S ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UCLA MEDICAL CENTER   (United States)

^c OLIVE VIEW UCLA MEDICAL CENTER   (United States)

^d BETH ISRAEL MEDICAL CENTER   (United States)

^e ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

Epstein Barr virus; Intravascular lymphoma; Natural killer cell; NK cell; Non Hodgkin lymphoma

Indexed keywords

CD2 ANTIGEN; CD20 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD5 ANTIGEN; CD56 ANTIGEN; CD7 ANTIGEN; CD8 ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; GRANZYME B; PERFORIN; PREDNISONE; T CELL INTRACYTOPLASMIC ANTIGEN 1; T LYMPHOCYTE ANTIGEN; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG; VINCRISTINE;

ADULT; ARTHRALGIA; ARTICLE; AUTOPSY; B LYMPHOCYTE; BONE MARROW; BONE MARROW BIOPSY; BRAIN; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CLINICAL FEATURE; EPSTEIN BARR VIRUS; ERYTHEMA; FEMALE; FEVER; GENE REARRANGEMENT; HISTIOCYTE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; KIDNEY; LARGE CELL LYMPHOMA; MALE; MENTAL HEALTH; MUSCLE WEAKNESS; MYALGIA; NATURAL KILLER CELL; OVARY; PANCYTOPENIA; PHENOTYPE; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; T LYMPHOCYTE; T LYMPHOCYTE RECEPTOR GENE; TREATMENT OUTCOME;

EID: 15744389810     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/X597G3QMXAFBCM5V     Document Type: Article

References (47)

1. Pfleger L, Tappeiner J. Zur kenntnis der systemisierten endotheliomatose der cutanen blutgefasse. Hautarzt. 1959;10:359-363.
2. Ansell J, Bhawan J, Cohen S, et al. Histiocytic lymphoma and malignant angioendotheliomatosis: one disease or two? Cancer. 1982;50:1506-1512.
3. Carroll TJ Jr, Schelper RL, Goeken JA, et al. Neoplastic angioendotheliomatosis: immunopathologic and morphologic evidence for intravascular malignant lymphomatosis. Am J Clin Pathol. 1986;85:169-175.
4. Mori S, Itoyama S, Mohri N, et al. Cellular characteristics of neoplastic angioendotheliosis: an immunohistological marker study of 6 cases. Virchows Arch A Pathol Anat Histopathol. 1985;407:167-175.
5. Sheibani K, Battifora H, Winberg CD, et al. Further evidence that "malignant angioendotheliomatosis" is an angiotropic large-cell lymphoma. N Engl J Med. 1986;314:943-948.
6. Wick MR, Mills SE, Scheitbauer BW, et al. Reassessment of malignant "angioendotheliomatosis": evidence in favor of its reclassification as "intravascular lymphomatosis." Am J Surg Pathol. 1986;10:112-123.
7. Domizio P, Hall PA, Cotter F, et al. Angiotropic large cell lymphoma (ALCL): morphological, immunohistochemical and genotypic studies with analysis of previous reports. Hematol Oncol. 1989;7:195-206.
8. Gatter KC, Warnke RA. Intravascular large B-cell lymphoma. In: Jaffe ES, Harris NL, Stein H, et al, eds. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001:177-178. World Health Organization Classification of Tumours.
9. Anagnostopoulos I, Dallenbach F, Stein H. Diffuse large cell lymphoma. In: Knowles DM, ed. Neoplastic Hematopathology. 2nd ed. New York, NY: Lippincott Williams & Wilkins; 2001:855-913.
10. Ko YH, Han JH, Go JH, et al. Intravascular lymphomatosis: a clinicopathological study of two cases presenting as an interstitial lung disease. Histopathology. 1997;31:555-562.
11. Malicki DM, Suh YK, Fuller GN, et al. Angiotropic (intravascular) large cell lymphoma of T-cell phenotype presenting as acute appendicitis in a patient with acquired immunodeficiency syndrome. Arch Pathol Lab Med. 1999;123:335-337.
12. Sepp N, Schuler G, Romani N, et al. "Intravascular lymphomatosis" (angioendotheliomatosis): evidence for a T-cell origin in two cases. Hum Pathol. 1990;21:1051-1058.
13. Sangueza O, Hyder DM, Sangueza P. Intravascular lymphomatosis: report of an unusual case with T cell phenotype occurring in an adolescent male. J Cutan Pathol. 1992;19:226-231.
14. Au WY, Shek WH, Nicholls J, et al. T-cell intravascular lymphomatosis (angiotropic large cell lymphoma): association with Epstein-Barr viral infection. Histopathology. 1997;31:563-567.
15. O'Grady JT, Shahidullah H, Doherty VR, et al. Intravascular histiocytosis. Histopathology. 1994;24:265-268.
16. Snowden JA, Angel CA, Winfield DA, et al. Angiotropic lymphoma: report of a case with histiocytic features. J Clin Pathol. 1997;50:67-70.
17. Hsiao CH, Su IJ, Hsieh SW, et al. Epstein-Barr virus-associated intravascular lymphomatosis within Kaposi's sarcoma in an AIDS patient. Am J Surg Pathol. 1999;23:482-487.
18. Santucci M, Pimpinelli N, Massi D, et al. Cytotoxic/natural killer cell cutaneous lymphomas; report of EORTC Cutaneous Lymphoma Task Force Workshop. Cancer. 2003;97:610-627.
19. O'Connell FP, Pinkus JL, Pinkus GS. CD138 (syndecan-1), a plasma cell marker: immunohistochemical profile in hematopoietic and nonhematopoietic neoplasms. Am J Clin Pathol. 2004;121:254-263.
20. de Vos S, Hoffman W-K, Grogan TM, et al. Gene expression profile of serial samples of transformed lymphomas. Lab Invest. 2003;83:271-285.
21. Kutok JL, Pinkus GS, Dorfman DM, et al. Inflammatory pseudotumor of lymph node and spleen: an entity biologically distinct from inflammatory myofibroblastic tumor. Hum Pathol. 2001;32:1382-1387.
22. DiGiuseppe JA, Nelson WG, Seifter EJ, et al. Intravascular lymphomatosis: a clinicopathologic study of 10 cases and assessment of response to chemotherapy. J Clin Oncol. 1994;12:2573-2579.
23. Yegappan S, Coupland R, Arber DA, et al. Angiotropic lymphoma: an immunophenotypically and clinically heterogeneous lymphoma. Mod Pathol. 2001;14:1147-1156.
24. Qian X, Kuo FC, DeGirolami U, et al. Intravascular lymphoma: a clinicopathologic, immunophenotypic, and molecular genetic study [abstract]. Mod Pathol. 2003;16:249A.
25. D'Agati V, Sablay LB, Knowles DM, et al. Angiotropic large cell lymphoma (intravascular malignant lymphomatosis) of the kidney: presentation as minimal change disease. Hum Pathol. 1989;20:263-268.
26. Rubin MA, Cossman J, Freter CE, et al. Intravascular large cell lymphoma coexisting within hemangiomas of the skin. Am J Surg Pathol. 1997;21:860-864.
27. Estalilla OC, Koo CH, Brynes RK, et al. Intravascular large B-cell lymphoma; a report of five cases initially diagnosed by bone marrow biopsy. Am J Clin Pathol. 1999;112:248-255.
28. Murase T, Nakamura S. An Asian variant of intravascular lymphomatosis: an updated review of malignant histiocytosis-like B-cell lymphoma. Leuk Lymphoma. 1999;33:459-473.
29. Murase T, Nakamura S, Kawauchi K, et al. An Asian variant of intravascular large B-cell lymphoma: clinical, pathological and cytogenetic approaches to diffuse large B-cell lymphoma associated with haemophagocytic syndrome. Br J Haematol. 2000;111:826-834.
30. Murase T, Nakamura S, Tashiro K, et al. Malignant histiocytosis-like B-cell lymphoma, a distinct pathologic variant of intravascular lymphomatosis: report of five cases and review of the literature. Br J Haematol. 1997;99:656-664.
31. Shimazaki C, Inaba T, Okano A, et al. Clinical characteristics of B-cell lymphoma-associated hemophagocytic syndrome (B-LAHS): comparison of CD5+ with CD5- B-LAHS. Intern Med. 2001;40:878-882.
32. Kanda M, Suzumiya J, Ohshima K, et al. Intravascular large cell lymphoma: clinicopathological, immuno-histochemical and molecular genetic studies. Leuk Lymphoma. 1999;34:569-580.
33. Hsiao CH, Lee WI, Chang SL, et al. Angiocentric T-cell lymphoma of the intestine: a distinct etiology of ischemic bowel disease. Gastroenterology. 1996;110:985-990.
34. Khalidi HS, Brynes RK, Browne P, et al. Intravascular large B-cell lymphoma: the CD5 antigen is expressed by a subset of cases. Mod Pathol. 1998;11:983-988.
35. Otrakji CL, Voigt W, Amador A, et al. Malignant angioendotheliomatosis: A true lymphoma: a case of intravascular malignant lymphomatosis studied by Southern blot hybridization analysis. Hum Pathol. 1988;19:475-478.
36. DiGuiseppe JA, Hartmann DP, Freter C, et al. Molecular detection of bone marrow involvement in intravascular lymphomatosis. Mod Pathol. 1997;10:33-37.
37. Davey DD, Munn R, Smith LW, et al. Angiotrophic lymphoma: presentation in uterine vessels with cytogenetic studies. Arch Pathol Lab Med. 1990;114:879-882.
38. Shimazaki C, Inaba T, Shimura K, et al. B-cell lymphoma associated with haemophagocytic syndrome: a clinical, immunological and cytogenetic study. Br J Haematol. 1999;104:672-679.
39. Ichikawa N, Kobayashi H, Ito T, et al. Chromosomal aberrations after stimulation with lipopolysaccharide in a patient with Asian variant intravascular lymphomatosis [letter]. Cancer Genet Cytogenet. 2000;120:83-84.
40. Tsukadaira A, Okubo Y, Ogasawara H, et al. Chromosomal aberrations in intravascular lymphomatosis. Am J Clin Oncol. 2002;25:178-181.
41. Khoury H, Lestou VS, Gascoyne RD, et al. Multicolor karyotyping and clinicopathological analysis of three intravascular lymphoma cases. Mod Pathol. 2003;16:716-724.
42. Wong KF, Zhang YM, Chan JK. Cytogenetic abnormalities in natural killer cell lymphoma/leukemia: is there a consistent pattern? Leuk Lymphoma. 1999;34:241-250.
43. Jaffe ES. Classification of natural killer (NK) cell and NK-like T-cell malignancies. Blood. 1996;87:1207-1210.
44. Kwong YL, Chan AC, Liang RH. Natural killer cell lymphoma/leukemia: Pathology and treatment. Hematol Oncol. 1997;15:71-79.
45. Siu LL, Chan JK, Kwong YL. Natural killer cell malignancies: clinicopathologic and molecular features. Histol Histopathol. 2002;17:539-554.
46. Kanegane H, Yachie A, Miyawaki T, et al. EBV-NK cells interactions and lymphoproliferative disorders. Leuk Lymphoma. 1998;29:491-498.
47. Shimokawa I, Higami Y, Sakai H, et al. Intravascular malignant lymphomatosis: a case of T-cell lymphoma probably associated with T-cell lymphotropic virus. Hum Pathol. 1991;22:200-202.